The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase–dependent lipoxin production
Open accessAbstract
Th1 type cytokine responses are critical in the control of Mycobacterium tuberculosis infection. Recent findings indicate that 5-lipoxygenase-dependent (5-LO-dependent) lipoxins regulate host IL-12 production in vivo. Here, we establish lipoxins as key chemical mediators in resistance to M. tuberculosis infection. High levels of lipoxin A4 (LXA4) were detected in sera from infected WT but not infected 5-LO-deficient mice. Moreover, lungs from M. tuberculosis-infected 5-lo-/- animals showed increased IL-12, IFN-gamma, and NO synthase 2 (NOS2) mRNA levels compared with the same tissues in WT mice. Similarly, splenocyte recall responses were enhanced in mycobacteria-infected 5-lo-/- versus WT mice. Importantly, bacterial burdens in 5-lo-/- lungs were significantly lower than those from WT mice, and this enhancement in the resistance of the 5-lo-/- animals to M. tuberculosis was completely prevented by administration of a stable LXA4 analog. Together our results demonstrate that lipoxins negatively regulate protective Th1 responses against mycobacterial infection in vivo and suggest that the inhibition of lipoxin biosynthesis could serve as a strategy for enhancing host resistance to M. tuberculosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,677
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180
Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
Jouanguy, E., Altare, F., Lamhamedi, S., Revy, P., Emile, J.-F., Newport, M., Levin, M., Blanche, S., Seboun, E., Fischer, A., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352604 · Cited by 895
Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency
Altare, F., Durandy, A., Lammas, D., Emile, J.-F., Lamhamedi, S., Le Deist, F., Drysdale, P., Jouanguy, E., Döffinger, R., Bernaudin, F., et al. (1998) · Science · doi:10.1126/science.280.5368.1432 · Cited by 845
Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient Patients
Jong, R. D., Altare, F., Haagen, I.-A., Elferink, D. G., Boer, T. D., van Breda Vriesman, P. J. C., Kabel, P. J., Draaisma, J. M. T., van Dissel, J. T., Kroon, F. P., et al. (1998) · Science · doi:10.1126/science.280.5368.1435 · Cited by 821
IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection
Flynn, J. L., Goldstein, M. M., Triebold, K. J., Sypek, J., Wolf, S., & Bloom, B. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2515 · Cited by 324
The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.
Cooper, A. M., Roberts, A. D., Rhoades, E. R., Callahan, J. E., Getzy, D. M., & Orme, I. M. (1995) · PubMed Central · Cited by 308
Canny, G., Levy, O., Furuta, G. T., Narravula-Alipati, S., Sisson, R. B., Serhan, C. N., & Colgan, S. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052533799 · Cited by 295
Self-citationIsrael, E. (1996) · JAMA · doi:10.1001/jama.1996.03530360041036 · Cited by 295
Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C. N., & Sher, A. (2002) · Nature Immunology · doi:10.1038/ni745 · Cited by 258
Self-citationClish, C. B., O’Brien, J. A., Gronert, K., Stahl, G. L., Petasis, N. A., & Serhan, C. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8247 · Cited by 212
Self-citationSerhan, C. N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00047-3 · Cited by 205
Self-citationAliberti, J., Serhan, C., & Sher, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021183 · Cited by 204
Self-citationScanga, C. A., Bafica, A., Feng, C. G., Cheever, A. W., Hieny, S., & Sher, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.4.2400-2404.2004 · Cited by 201
Self-citationHachicha, M., Pouliot, M., Petasis, N. A., & Serhan, C. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1923 · Cited by 199
Self-citationHost persistence: exploitation of anti-inflammatory pathways by Toxoplasma GONDII
Aliberti, J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1547 · Cited by 161
Self-citationBannenberg, G. L., Moussignac, R., Gronert, K., Devchand, P. R., Schmidt, B. A. R., Guilford, W. J., Bauman, J. G., Subramanyam, B., Perez, H. D., Parkinson, J. F., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705912 · Cited by 140
Self-citationBandeira‐Melo, C., Bozza, P. T., Diaz, B. L., Cordeiro, R. S. B., Jose, P. J., Martins, M. A., & Serhan, C. N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2267 · Cited by 116
Self-citationExogenous Pathogen and Plant 15-Lipoxygenase Initiate Endogenous Lipoxin A4 Biosynthesis
Bannenberg, G. L., Aliberti, J., Hong, S., Sher, A., & Serhan, C. N. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031325 · Cited by 98
Self-citationRamstedt, U., Ng, J., Wigzell, H., et al. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.5.3434 · Cited by 95
Jung, Y., LaCourse, R., Ryan, L., & North, R. J. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6436-6443.2002 · Cited by 82
Jung, Y., Ryan, L., LaCourse, R., & North, R. J. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01645.x · Cited by 59
Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia
Levy, O., Canny, G., Serhan, C. N., & Colgan, S. P. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310795 · Cited by 54
Self-citationEndogenous Inhibition of Antimycobacterial Immunity by IL‐10 Varies between Mycobacterial Species
Roach, D. R., Martin, E., Bean, A. G. D., Rennick, D. M., Briscoe, H., & Britton, W. J. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.00952.x · Cited by 53
Devchand, P. R., Schmidt, B. A. R., Primo, V., Zhang, Q., Arnaout, M. A., Serhan, C. N., & Nikolic, B. (2005) · The FASEB Journal · doi:10.1096/fj.04-2565com · Cited by 34
Self-citationEffects of modulating TGF-beta;1 on immune responses to mycobacterial infection in guinea pigs
Dai, G., & McMurray, D. N. (1999) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0198 · Cited by 29
Genetic susceptibility to pulmonary tuberculosis in Cambodia
Goldfeld, A. E. (2003) · Tuberculosis · doi:10.1016/j.tube.2003.08.007 · Cited by 21
Cited by
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Cell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,162
Serhan, C. N. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 997
Self-citationProresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 807
Self-citationSpecialized pro-resolving mediators: endogenous regulators of infection and inflammation
Basil, M. C., & Levy, B. D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.4 · Cited by 791
Metadata
- Authors
- Bafica, A., Scanga, C. A., Serhan, C., Machado, F., White, S., Sher, A., & Aliberti, J.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-06-01
- Volume
- 115
- Issue
- 6
- Pages
- 1601-1606
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2102189561
- Cited by
- 253
- References
- 28
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.